BRAF and colonic neoplasm: According to the literature, the discovery of v-raf murine sarcoma viral oncogene homolog B1 (BRAF) V600E mutations indicates the possibility of colon cancer with aggressive phenotypes, and such mutations have become a significant prognostic biomarker, especially in end-stage cases [6].